Results 291 to 300 of about 4,193,206 (400)
Low‐Cost New Glaucoma Drainage Device in Indonesia: One Year Follow‐Up of 252 Subjects
ABSTRACT Background To evaluate the early efficacy and safety of a new polymethyl methacrylate 200 mm2 non‐valved glaucoma drainage device (GDD) designed for Indonesian use over a 12 month period. Methods This was a prospective study following subjects with various forms of refractory glaucoma aged ≥ 7 years old followed for 12 months. The subjects had
Virna Dwi Oktariana Asrory+1 more
wiley +1 more source
Effect of intraocular pressure on crystalline lens oscillations: a computational study using porcine eye model. [PDF]
Dahaghin A+4 more
europepmc +1 more source
Cataract Surgery in the Small Adult Eye: A Review
ABSTRACT Modern cataract surgery continues to advance, yet intraocular lens (IOL) based surgery in the small adult eye remains challenging. Thorough preoperative assessment and surgical preparation optimise postoperative outcomes in these cases. Advances in IOL power calculation, including artificial intelligence‐driven formulas, improve accuracy ...
Jonathan E. Moore+2 more
wiley +1 more source
Factors Affecting Intraocular Pressure [PDF]
openaire +5 more sources
Longitudinal Change in Retinal Nerve Fiber Layer Thickness and Intraocular Pressure in Young Adults. [PDF]
Lee SS, Lingham G, Hewitt AW, Mackey DA.
europepmc +1 more source
Intraocular pressure‐lowering medications and long‐term outcomes of selective laser trabeculoplasty
D. M. Woo+3 more
semanticscholar +1 more source
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang+8 more
wiley +1 more source